Guardant Health, Inc. (GH)
Nasdaq: GH · Services-Medical Laboratories · Palo Alto, CA · filing with the SEC since 2014
Who owns Guardant Health, Inc.
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 5.2% of Common Stock, as its SCHEDULE 13G/A filed Jul 28, 2026 says.
Directors and officers
19
report now, of 30 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 28, 2026 · Common Stock · 7.5% in Apr 17, 2025
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
T. Rowe Price Associates, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · COMMON STOCK · reported falling below 5%, from 5.4% in May 15, 2026
Deep Track Capital, LP
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.00001 Par Value · reported falling below 5%
Cadian Capital Management, LP
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock, par value $0.00001 per share · reported falling below 5%
Wellington Management Group LLP
SCHEDULE 13G/A · filed Feb 10, 2025 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What GH reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
MetaSight Diagnostics Ltd
A company bought · acquisition · owns, named in the 10-K filed Feb 19, 2026
12 subsidiaries in 8 countries, from the list filed with the 10-K filed Feb 20, 2025.
Insider tradesForm 4
141sales
1purchases
56sales on a scheduled plan
15people selling
$173Msold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window15 of 50 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Talasaz Amirali | Co-Chief Executive Officer | 28 | $84.3M | 19 | 0 | $0 |
| Eltoukhy Helmy | Co-Chief Executive Officer | 9 | $22.0M | 0 | 0 | $0 |
| Freeman Chris | Chief Commercial Officer | 16 | $16.9M | 0 | 0 | $0 |
| Monroe Terilyn J. | Chief People Officer | 19 | $15.9M | 14 | 0 | $0 |
| Bell Michael Brian | Chief Financial Officer | 14 | $8.8M | 0 | 0 | $0 |
| Clark Ian T | director | 6 | $6.1M | 0 | 0 | $0 |
| Kalia Kumud | Chief Information Officer | 8 | $5.9M | 0 | 1 | $100,000 |
| Chudova Darya | Chief Technology Officer | 4 | $4.4M | 0 | 0 | $0 |
| Saia John G. | Chief Legal Officer | 5 | $3.4M | 5 | 0 | $0 |
| Krognes Steve E. | director | 5 | $2.4M | 0 | 0 | $0 |
| Joyce Meghan V. | director | 4 | $1.3M | 4 | 0 | $0 |
| Hidalgo Medina Manuel | director | 9 | $800,000 | 0 | 0 | $0 |
| Tariq Musa | director | 11 | $400,000 | 11 | 0 | $0 |
| Azar Alex M II | director | 2 | $200,000 | 2 | 0 | $0 |
| Potter Myrtle S | director | 1 | $200,000 | 1 | 0 | $0 |